TY - JOUR
T1 - Health Supervision for Children and Adolescents With Sickle Cell Disease
T2 - Clinical Report
AU - Section on Hematology/Oncology; AMERICAN SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY
AU - Yates, Amber M.
AU - Aygun, Banu
AU - Nuss, Rachelle
AU - Rogers, Zora R.
AU - Wetmore, Cynthia
AU - Dickens, David
AU - Majumdar, Suvankar
AU - Rogers, Zora R.
AU - Stoffman, Jayson
AU - Warwick, Anne
AU - Yates, Amber
AU - Sheikh, Irtiza
AU - Mendonca, Eneida A.
AU - Michel, Jeremy J.
AU - Kirkwood, Suzanne
AU - Graham, Doug
AU - Hastings, Caroline
AU - DiPaola, Jorge
AU - Hord, Jeffrey
AU - Alexander, Sarah
AU - Huh, Winston
AU - Jeng, Michael
AU - Velez, Maria
AU - Wechsler, Dan
AU - Hooker, Ryan
N1 - Publisher Copyright:
© 2024 by the American Academy of Pediatrics
PY - 2024/8/1
Y1 - 2024/8/1
N2 - Sickle cell disease (SCD) is a group of complex genetic disorders of hemoglobin with multisystem manifestations. The scope of this clinical report is such that in-depth recommendations for management of all complications is not possible. Rather, the authors present an overview focused on the practical management of children and adolescents with SCD and the complications that are of particular relevance to pediatric primary care providers. References with detailed commentary provide further information. Timely and appropriate treatment of acute illness is critical, because life-threatening complications may develop rapidly. Specialized comprehensive medical care decreases morbidity and mortality during childhood. The provision of comprehensive care is a time-intensive endeavor that includes ongoing patient and family education, periodic comprehensive evaluations and other disease-specific health maintenance services, nursing support, psychosocial care, and genetic counseling. Ideally, this care includes comanagement by the pediatrician or other pediatric primary care provider and a team of specialist SCD experts: Hematologist, other pediatric specialists, advanced practice providers, nurse specialists, social workers, patient navigators, and educational liaisons.
AB - Sickle cell disease (SCD) is a group of complex genetic disorders of hemoglobin with multisystem manifestations. The scope of this clinical report is such that in-depth recommendations for management of all complications is not possible. Rather, the authors present an overview focused on the practical management of children and adolescents with SCD and the complications that are of particular relevance to pediatric primary care providers. References with detailed commentary provide further information. Timely and appropriate treatment of acute illness is critical, because life-threatening complications may develop rapidly. Specialized comprehensive medical care decreases morbidity and mortality during childhood. The provision of comprehensive care is a time-intensive endeavor that includes ongoing patient and family education, periodic comprehensive evaluations and other disease-specific health maintenance services, nursing support, psychosocial care, and genetic counseling. Ideally, this care includes comanagement by the pediatrician or other pediatric primary care provider and a team of specialist SCD experts: Hematologist, other pediatric specialists, advanced practice providers, nurse specialists, social workers, patient navigators, and educational liaisons.
UR - https://www.scopus.com/pages/publications/85200424083
U2 - 10.1542/peds.2024-066842
DO - 10.1542/peds.2024-066842
M3 - Article
C2 - 39034826
AN - SCOPUS:85200424083
SN - 0031-4005
VL - 154
JO - Pediatrics
JF - Pediatrics
IS - 2
M1 - e2024066842
ER -